Hemab Therapeutics A/S has completed an oversubscribed US$157m Series C financing round led by Sofinnova Partners to accelarate and expand its pipeline in bleeding disorders and thrombosis treatments.
ADVERTISEMENT
Tag Archive for: Thrombosis
German biotech spin-out Emfret Analytics GmbH & Co. KG has presented a first in class anticoagulant that helps preventing heart attacks and stroke while showing less adverse effects than approved meds.


adobe stock photos - Jiraporn
Stefan Navarro, Experimental Biomedicine I / University Hospital Würzburg, Germany